Figure 1: Ex-vivo IFNγ ELISpot responses.
(A) Shows IFNγ to Ag85A peptides in the aerosol and intradermal groups. IFNγ increased significantly for 12 and 24 weeks after aerosol and intradermal vaccination respectively. No significant difference was detected in the IFNγ between the groups (p=0·9212). (B) Anti-vector responses: IFNγ responses were assessed to CD4+ and CD8+ T cell epitopes present in Vaccinia and MVA.
I. MVA CD4+ T cell IFNγ: Significant increase in response followed aerosol vaccination at 1 and 2 weeks, p= 0·0469 and 0·0293 respectively. The intradermal response increased significantly at week 2 post-vaccination (p=0·0352). Mann-Whitney test for AUC shows that the aerosol group had significantly higher MVA CD4+ T cell IFNγ response than the intradermal group (p=0·0358). II. MVA CD8+ T cell IFNγ: Responses increased significantly in the aerosol group at 2, 4, and 12 weeks post-vaccination (p<0·05), whereas the intradermal group MVA-CD8 response increased significantly from the first week post-vaccination up to week 4 (p<0·05). Levels of MVA CD8+ T cell IFNγ were not significantly different in the two groups (p=0·5319).
Box and whisker plots show median, interquartile range, and minimum and maximum values. Presented results are antigen-specific with unstimulated background responses subtracted. Serum anti-vector IgA peaked at D14 in the intradermal group and remained significantly higher up to the last follow up time point, no significant differences were observed in the aerosol group. The intradermal group IgA response was significantly higher than the aerosol group (p=0·0003).
IgM to MVA increased significantly in the intradermal vaccinated group at days 14, 28, and 84 post-vaccination, while levels remained unchanged in the aerosol group. However, these IgM responses, detected in the intradermal group were not significantly different to the aerosol group's response (p=0·079). Box and whisker plots show median, interquartile range, and minimum and maximum values.
